Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

A scalp infection can look like alopecia areata and get worse if treated incorrectly.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Topical tofacitinib is effective and safe for treating alopecia areata.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib may effectively treat nail changes in alopecia areata.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

Adipose-derived stem cells may help with hair loss, but more research is needed.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Different types of hair loss require specific treatments, and new treatments are being developed.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.